Interim / Quarterly Report • Oct 24, 2024
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
Interim Report for the six months ended 30 June 2024

Maven Income and Growth VCT 4 PLC (the Company) is a public limited company limited by shares. It was incorporated in Scotland on 26 August 2004 with company registration number SC272568. Its registered office is at Kintyre House, 205 West George Street, Glasgow G2 2LW.
The Company is a venture capital trust (VCT) and its shares are listed on the premium segment of the Official List and traded on the Main Market of the London Stock Exchange.
The Company aims to achieve long-term capital appreciation and generate income for Shareholders.
The Articles of Association (Articles) require the Directors to put a proposal for the continuation of the Company, in its then form, to Shareholders at the Company's Annual General Meeting (AGM) to be held in 2030 or, if later, at the AGM following the fifth anniversary of the latest allotment of new shares.
Shares in the Company can be purchased and sold in the market through a stockbroker. For qualifying investors buying shares on the open market:
The Stockbroker to the Company is Shore Capital Stockbrokers Limited (020 7647 8132).
The Company currently conducts its affairs so that the shares issued by it can be recommended by financial advisers to ordinary retail investors in accordance with the rules of the Financial Conduct Authority (FCA) in relation to non-mainstream investment products, and intends to continue to do so for the foreseeable future. The Company's shares are excluded from the FCA's restrictions that apply to non-mainstream investment products because they are shares in a VCT and the returns to investors are predominantly based on investments in private companies or publicly quoted securities.
Shareholders in a number of UK registered companies have received unsolicited calls from organisations, usually based overseas or using false UK addresses or phone lines routed abroad, offering to buy shares at prices much higher than their current market values or to sell non-tradeable, overpriced, high risk or even non-existent securities. Whilst the callers may sound credible and professional, Shareholders should be aware that their intentions are often fraudulent and high-pressure sales techniques may be applied, often involving a request for an indemnity or a payment to be provided in advance.
If you receive such a call, you should exercise caution and, based on advice from the FCA, the following precautions are suggested:
Action Fraud
Telephone: 0300 123 2040
Website: actionfraud.police.uk
FCA
Telephone: 0800 111 6768 (freephone)
Website: fca.org.uk/scamsmart

| Corporate Summary | 02 |
|---|---|
| Financial Highlights | 05 |
| Interim Review | 08 |
| Investment Portfolio Summary | 22 |
| Portfolio Analysis | 28 |
| Income Statement | 29 |
|---|---|
| Statement of Changes in Equity | 30 |
| Balance Sheet | 32 |
| Cash Flow Statement | 33 |
| Notes to the Financial Statements | 34 |
| Directors' Responsibility Statement | 36 |
|---|---|
| Glossary | 37 |
| Contact Information | 39 |


The above chart shows the NAV total return per Ordinary Share as at 31 December in each year, except in 2024, which is at 30 June. Dividends that have been declared but not yet paid are included in the NAV at the balance sheet date.
| 30 June 2024 |
31 December 2023 |
30 June 2023 |
|
|---|---|---|---|
| NAV | £89,150,000 | £83,917,000 | £89,694,000 |
| NAV per Ordinary Share | 62.19p | 61.71p | 64.92p |
| Dividends paid per Ordinary Share to date* | 92.85p | 91.10p | 89.35p |
| NAV total return per Ordinary Share1 * |
155.04p | 152.81p | 154.27p |
| Share price2 | 57.00p | 60.00p | 63.00p |
| Discount to NAV* | 8.35% | 2.77% | 2.96% |
| Ordinary Shares in issue | 143,341,152 | 135,982,341 | 138,160,850 |
| Year ended 31 December |
Payment date | Interim/final | Payment (p) |
Annual payment (p) |
Annual yield (%)3 |
|---|---|---|---|---|---|
| 2006-2019 | 77.60 | ||||
| 2020 | 2 October 2020 | Interim | 1.00 | ||
| 21 May 2021 | Final | 2.00 | 3.00 | 4.23 | |
| 2021 | 1 October 2021 | Interim | 2.00 | ||
| 11 March 2022 | Second interim | 2.00 | |||
| 20 May 2022 | Final | 1.00 | 5.00 | 7.11 | |
| 2022 | 7 October 2022 | Interim | 2.00 | ||
| 23 May 2023 | Final | 1.75 | 3.75 | 5.01 | |
| 2023 | 13 October 2023 | Interim | 1.75 | ||
| 24 May 2024 | Final | 1.75 | 3.50 | 5.12 | |
| Total dividends paid since inception |
92.85 | ||||
| 2024 | 18 October 2024 | Interim | 2.00 | ||
| Total dividends paid or declared since inception |
94.85 |
1 Sum of current NAV per Ordinary Share and dividends paid per Ordinary Share to date (excluding initial tax relief).
2 Closing mid-market price at the period end (Source: IRESS).
3 The total dividends paid for the financial year, expressed as a percentage of the NAV per Ordinary Share at the immediately preceding year end.
*Definitions of these Alternative Performance Measures (APMs) can be found in the Glossary on pages 37 and 38 of this Interim Report.
| 31 December 2023 £'000 |
Valuation % |
Net investment/ (disinvestment) £'000 |
Appreciation/ (depreciation) £'000 |
Valuation 30 June 2024 £'000 % |
||
|---|---|---|---|---|---|---|
| Unlisted investments | ||||||
| Equities | 48,291 | 57.5 | 652 | 4,325 | 53,268 | 59.8 |
| Loan stock | 13,382 | 15.9 | 98 | 5 | 13,485 | 15.1 |
| 61,673 | 73.4 | 750 | 4,330 | 66,753 | 74.9 | |
| AIM investments1 | ||||||
| Equities | 3,894 | 4.6 | 93 | (817) | 3,170 | 3.6 |
| Other investments2 | ||||||
| OEICs | 2,035 | 2.4 | 26 | (25) | 2,036 | 2.3 |
| MMFs | 4,000 | 4.8 | 1,000 | - | 5,000 | 5.5 |
| Investment trusts | 5,635 | 6.7 | - | 142 | 5,777 | 6.5 |
| Total investments | 77,237 | 91.9 | 1,869 | 3,630 | 82,736 | 92.8 |
| Other net assets | 6,680 | 8.1 | (266) | - | 6,414 | 7.2 |
| Net assets | 83,917 | 100.0 | 1,603 | 3,630 | 89,150 | 100.0 |
1 Shares traded on the Alternative Investment Market (AIM) and the Main Market of the London Stock Exchange.
2 These holdings represent the treasury management portfolio, which has been constructed from a range of carefully selected, permitted non-qualifying holdings in open-ended investment companies (OEICs), money market funds (MMFs) and investment trusts.
In the six months to 30 June 2024, your Company has made further positive progress and it is pleasing to report an increase in NAV total return. Since the year end, there has been a strong level of M&A activity across the private company portfolio, which has resulted in the completion of five profitable realisations, including several high value exits to strategic US buyers. In June, the sale of the residual interest in Quorum Cyber completed, generating a total return of 8.2x cost over the life of the investment and, in August, the partial sale of MirrorWeb completed, generating a total return of 4.7x cost, with the partial exit from Novatus Global completing in early September and generating a total return of 4.7x cost. With MirrorWeb and Novatus, the exit considerations consisted of a combination of cash and a continuing equity stake, which allows your Company to participate in the future growth of these businesses with scope for a further return in the future. In recognition of the exit activity and the commitment to make regular tax free distributions, an increased interim dividend of 2.00p per share has been declared for payment in October 2024.
In the year to date, your Company has completed five profitable private company exits to UK and US buyers, helping to validate the Manager's investment strategy and sector focus. Following a muted period for M&A within the technology sector in 2023, the market has recovered strongly. Notably, there has been a reemergence of US private equity buyers who are attracted to UK speciality software companies that have a market leading product and a clear path to scalable growth. A key part of their acquisition rationale is to provide financial resource to help these businesses accelerate growth plans and realise their full potential.
In early June, the final exit from cyber security specialist Quorum Cyber completed with the sale of the residual holding. Your Company first invested in Quorum in 2020, backing an experienced team that had established a leading position in a high growth market. Following a period of rapid expansion, the investment was partially realised through a sale to UK private equity house Livingbridge in December 2021, generating an initial return of 6.5x cost over an 18 month holding period. This transaction provided Quorum with additional capital to support the next phase of its strategic development and, in recognition of the growth prospects, the Maven VCTs retained a minority equity interest in the business in order to participate in its future success. In June this year, a final exit from this investment was achieved through a sale of the business to US private equity firm, Charlesbank Capital Partners, taking the total proceeds to 8.2x cost over the life of the investment.
A further notable exit was the partial sale of digital archiving specialist MirrorWeb, which completed in August 2024. Your Company first invested in MirrorWeb in 2020, supporting an ambitious management team who had developed a disruptive software platform with significant growth potential and a large addressable market. Since investment, the business consistently delivered strong revenue growth and established a leading position in the communications surveillance market, with a focus on the financial services sector where the platform supports regulatory requirements in relation to data archiving. In 2023, the business successfully expanded into the US, which led to an unsolicited approach to acquire the business from a US private equity buyer. Following this approach, a competitive exit process was initiated, with the sale to US private equity acquirer MainSail completing in August. The exit generated a total return of 4.7x cost, comprising of a cash consideration and an ongoing equity stake that enables your Company to maintain an economic interest in the business with the potential for a further return in the future.
In early September 2024, the partial sale of regtech specialist Novatus Global completed, achieving the highest value sale price to date from your Company's unlisted technology portfolio. Following investment by your Company, Novatus made rapid commercial progress, capitalising on the growth opportunities within its core market, where its advisory services and software platform helps financial institutions to prevent and resolve regulatory and compliance issues. Over the past two years, the business achieved a 250% increase in annual recurring revenue (ARR), driven by the development of its proprietary transaction reporting software platform, which is gaining market traction and a strong reputation. The business recently opened its first international office in Australia to capture the significant opportunity in this region. Novatus received an unsolicited acquisition approach from US private equity firm Silversmith Capital Partners at a premium to carrying value, reflective of the strategic value of the technology.
The exit generated a total return of 4.7x cost, which includes cash and an ongoing equity element that enables your Company to participate in the future growth of this business.
Specialist electronics manufacturer CB Technology was one of the more mature holdings in the portfolio and, following a period of strong trading performance, an exit process was initiated in 2023. An offer to acquire the business was subsequently received from a private equity backed trade acquirer, with the exit completing in early September 2024 and generating a total return of 2.9x cost. In addition, in May 2024 your Company completed the exit from graduate recruitment specialist GradTouch, with a sale to a UK private equity house that generated a total return of 1.5x cost, inclusive of a small deferred element.
Achieving profitable exits in order to maximise Shareholder returns and distributions remains a key priority. However, this has to be balanced against selling a business too early before its value has been fully optimised. In cases like Quorum, MirrorWeb and Novatus, where a business is performing strongly and has the potential to become a large and valuable asset, the Manager will seek to maintain an economic interest when structuring an exit. This approach allows your Company to generate a healthy initial cash return from a secondary transaction or partial sale, to help support the dividend programme, whilst retaining an ongoing equity interest in the business, which offers the potential for a further return in the future.
Your Company continues to make further progress in line with its long term growth strategy, which is focused on constructing a large and diverse portfolio of innovative companies that have the potential to grow rapidly and ultimately become attractive to a wide range of acquirers. During the reporting period, a total of £2.6 million was deployed through the addition of two new private companies to the portfolio, alongside the provision of follow-on funding to support the further development of 13 existing unlisted holdings, as well as two small AIM transactions. The investment strategy continues to focus on identifying entrepreneurial companies that operate in disruptive or high growth markets, where there is an opportunity to achieve scale over the medium term. Maven retains a strong preference for investing in companies that operate in dynamic sectors such as cyber security, software, niche manufacturing, data analytics, healthtech and training, where growth is less sensitive to consumer or discretionary spending and the revenue model tends to be recurring in nature, which provides good visibility on the growth trajectory of each portfolio company. To ensure that the business plan can be delivered, Maven also spends time assessing the calibre of management and their track record, recognising that experienced and cohesive teams are crucial to the success of early stage businesses.
In April 2024, your Company closed its most recent top-up Offer having raised a total of £5.8 million for the 2023/24 and 2024/25 tax years. These funds will enable your Company to progress its investment strategy which, over the past four years, has provided growth capital to more than 40 private companies, many of which are delivering strong growth and achieving a leading position in their respective markets.
The Board and the Manager recognise the importance of tax free distributions to Shareholders and will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the immediately preceding year end. This policy is under close and regular review by the Board and the Manager, particularly in light of the current level of profitable exit activity.
Decisions on distributions take into consideration a number of factors, including the realisation of capital gains, the adequacy of distributable reserves, the availability of surplus revenue and the VCT qualifying level, all of which are kept under close and regular review. As the portfolio continues to expand and a greater proportion of holdings are invested in younger companies with growth potential, the timing of distributions will be more closely linked to realisation activity, whilst also reflecting the Company's requirement to maintain its VCT qualifying level.
In respect of the year ending 31 December 2024, an increased interim dividend of 2.00p per share will be paid on 18 October 2024 to Shareholders who are on the register at 20 September 2024. Since the Company's launch, and after receipt of this interim dividend, a total of 94.85p per share will have been paid in tax free Shareholder distributions. It should be noted that the payment of a dividend reduces the NAV of the Company by the total amount of the distribution.
Your Company operates a DIS, through which Shareholders can, at any time, elect to have their dividend payments utilised to subscribe for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax relief applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances.
Shareholders can elect to participate in the DIS in respect of future dividends by completing a DIS mandate form and returning it to the Registrar (The City Partnership). In order for the DIS to apply to the 2024 interim dividend, the mandate form must be received before 4 October 2024, this being the relevant dividend election date. The mandate form, terms & conditions and full details of the scheme (including tax considerations) are available from the Company's webpages at: mavencp.com/migvct4. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com/login.
If a Shareholder is in any doubt about the merits of participating in the DIS, or their own tax status, they should seek advice from a suitably qualified adviser.
The most recent Offer for Subscription closed on 26 April 2024, with your Company raising a total of £5.8 million for the 2023/24 and 2024/25 tax years. All new shares in relation to this Offer have now been issued, with four allotments for the 2023/24 tax year and one allotment for the 2024/25 tax year.
This additional liquidity will facilitate the further expansion and development of the portfolio in line with the investment strategy. The funds raised will also allow your Company to maintain its share buy-back policy, whilst also spreading costs over a wider asset base, with the objective of maintaining a competitive ongoing charges ratio for the benefit of all Shareholders.
As announced on 18 June 2024, the Directors have elected to launch a new Offer for Subscription, which will run alongside Offers by the other Maven managed VCTs. Full details will be included in the Prospectus, which is expected to be published in Autumn 2024.
It is encouraging to report on the progress that has been achieved across the private equity portfolio, where most companies have continued to meet operational and financial targets as part of their business plans. Many of the earlier stage growth companies are now achieving scale and establishing strong positions in their respective markets and, in recognition of the progress achieved, the valuations of certain holdings have been uplifted.
Cyber security specialist CYSIAM continues to make positive progress, with revenues increasing by more than 200% since your Company first invested. The business is building a strong reputation as a leading provider of Managed Detection and Response (MDR) security services for protection against, detection of and response to cyber attacks. CYSIAM is a recognised expert in its field and, as an accredited member of the National Cyber Security Centre's Cyber Incident Response scheme, it can provide direct support to a range of organisations when they become victims of cyber attacks. CYSIAM operates in a dynamic, high growth market and the near term strategic objective remains to further pivot the business towards a Software as a Service (SaaS) model, which will result in an increased level of recurring revenue.
In 2021, your Company invested in Guru Systems, a supplier of hardware, software and data analytics designed to improve the performance and cost effectiveness of heat networks. Since investment, the business has gained commercial traction in an emerging sector that has positive ESG credentials. Heat networks are an important part of the government's decarbonisation strategy and are increasingly required to be included as part of the design of any new residential and commercial property developments. Given the strong growth potential of this market, Guru is well placed to achieve scale over the medium term.
Carbon reduction software specialist Manufacture 2030 has delivered impressive revenue growth over the past year, with ARR increasing by over 75%. The business provides a disruptive software solution that helps multinationals achieve Scope 3 carbon reduction targets by measuring, managing and reducing carbon emissions across their supply chain. The business is establishing a leading position in a high growth market, where its proposition is aligned with various carbon reduction initiatives including the United Nations Sustainable Development Goals. Manufacture 2030 partners with a wide range of blue chip clients, including Asda, Co-op, GSK, Toyota and Unilever, and has received a number of awards as a technology pioneer within this evolving sector. The near term objective is to expand its presence in North America, which is viewed as a key growth market.
Automotive ecommerce software specialist Rockar continues to increase its market share and is now a leading provider of a disruptive white label solution for buying and selling new and used cars online. The business has signed commercial agreements with various high profile automotive manufacturers such as BMW, Jaguar Land Rover, Toyota Motor Group and Volvo UK, with development work ongoing with several others. Rockar's new operating platform, Evolution, is gaining traction amongst clients, with a number already using or committed to migrating across to the new operating system. The business continues to deliver strong revenue growth and remains focused on building relationships with global automotive manufacturers, and the outlook for the year ahead is encouraging.
Digital payments software provider QikServe has made further encouraging commercial progress and is capitalising on the shift within the hospitality sector towards mobile ordering and pay-at-table technology. The business continues to expand its market presence in targeted sectors that include restaurants, international coffee chains and transportation hubs. QikServe has a growing estate, with more than 8,000 sites in over 40 countries and a healthy pipeline of near term opportunities, particularly in the US.
Contract software specialist Summize continues to make positive commercial progress, with ARR growing by almost 200% since the Maven VCTs first invested in October 2022. The business has developed an AI-powered digital contracting software solution that simplifies and streamlines the process for writing and renewing contracts, helping to drive operational efficiencies for customers. Since inception in 2018, Summize has secured numerous industry awards for its innovation and entrepreneurialism. Having established a strong foothold in the UK, the next phase of growth for the business is to expand into the US, where a significant market opportunity has been identified.
As may be expected with a large portfolio, there are a small number of investee companies that have not achieved commercial targets and are trading behind plan. Protective provisions have, therefore, been taken against the cost of certain holdings. The performance of fintech specialist Delio has been impacted by slower than expected sales cycles and, although corrective measures have been taken, the business continues to trade behind plan. As a result of significant underperformance, the Manager elected not to provide further support to Drovo and Turnkey, and the valuations of these holdings have been written down in full.
Your Company maintains a proactive approach to treasury management, where the objective remains to optimise the income generated from cash held prior to investment in VCT qualifying companies, whilst meeting the requirements of the Nature of Income condition. This is a mandatory part of the VCT legislation, which stipulates that not less than 70% of a VCT's income must be derived from shares or securities. During 2023, the rise in interest rates required the Board and the Manager to revise its approach and, following a whole of market review, the composition of the treasury management portfolio was expanded to include holdings in leading money market funds and openended investment companies (OEICs), alongside carefully selected London Stock Exchange listed investment trusts. This approach enables your Company to maintain compliance with the Nature of Income condition, whilst also generating a healthy new stream of income from the portfolio of treasury management holdings and cash.
In line with the liquidity requirements of your Company, there were several new investments and realisations within the Treasury Management portfolio, details of which can be found on pages 16 to 18 of this Interim Report.
During the reporting period, two new private companies were added to the portfolio:
The following investments were completed during the reporting period:
| Investments | Date | Sector | £'000 |
|---|---|---|---|
| New unlisted | |||
| Alderley Lighthouse Labs Limited1 | April & May 2024 | Pharmaceuticals, biotechnology & healthcare |
249 |
| Zing TopCo Limited (trading as Zing)1 |
April & May 2024 | Business services | 185 |
| Total new unlisted | 434 | ||
| Follow-on unlisted | |||
| Bud Systems Limited | May 2024 | Learning & development/ recruitment technology |
116 |
| Delio Limited | February 2024 | Software & technology | 125 |
| Draper & Dash Limited (trading as RwHealth)1 |
April & May 2024 | Pharmaceuticals, biotechnology & healthcare |
68 |
| Hublsoft Group Limited | April 2024 | Software & technology | 56 |
| Liftango Group Limited | March 2024 | Software & technology | 269 |
| mypura.com Group Limited (trading as Pura) |
March 2024 | Business services | 193 |
| Relative Insight Limited | February 2024 | Software & technology | 66 |
| Shortbite Limited (trading as Fixtuur) | April 2024 | Software & technology | 37 |
| Snappy Shopper Limited | April 2024 | Software & technology | 11 |
| Summize Limited | June 2024 | Software & technology | 348 |
| Turnkey Group (UK) Holdings Limited2 |
January, February, April & June 2024 |
Software & technology | 335 |
| XR Games Limited | February 2024 | Software & technology | 48 |
| Zinc Digital Business Solutions Limited1 | March & May 2024 | Software & technology | 239 |
| Total follow-on unlisted | 1,911 | ||
| Total unlisted | 2,345 |
| Investments | Date | Sector | £'000 |
|---|---|---|---|
| New AIM quoted | |||
| Cambridge Cognition Holdings PLC |
June 2024 | Pharmaceuticals, biotechnology & healthcare |
62 |
| Total new AIM quoted | 62 | ||
| Follow-on AIM quoted | |||
| GENinCode PLC | January 2024 | Pharmaceuticals, biotechnology & healthcare |
160 |
| Total follow-on AIM quoted | 160 | ||
| Total AIM quoted | 222 | ||
| Open-ended investment companies3 | |||
| Royal London Short Term Money Market Fund (Class Y Income) |
April 2024 | Money market fund | 1,000 |
| Total open-ended investment companies |
1,000 | ||
| Money market funds3 | |||
| Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3) |
May 2024 | Money market fund | 1,000 |
| BlackRock Institutional Sterling Liquidity Fund (Core) |
March 2024 | Money market fund | 1,000 |
| Fidelity Institutional Liquidity Sterling Fund (Class F) |
March 2024 | Money market fund | 1,000 |
| Goldman Sachs Sterling Liquid Reserves (Institutional) |
January 2024 | Money market fund | 1,000 |
| Total money market funds | 4,000 | ||
| Total investments | 7,567 |
1 Follow-on investment completed in two tranches.
2 Follow-on investment completed in four tranches.
3 Investments completed as part of the treasury management strategy.
At the period end, the portfolio comprised of 131 unlisted and quoted investments, at a total cost of £73.4 million.
In May 2024, the exit from graduate recruitment specialist GradTouch completed. Your Company first invested in GradTouch in November 2019, backing a team with a strategic plan to build a market leading position in the graduate recruitment market. Throughout the period of ownership, the company achieved steady organic growth alongside a series of self funded, complementary acquisitions that helped to transform the business. During the period under review, an offer to acquire the business was received from UK private equity house Pelican Capital, and the exit generated a total return of 1.5x cost, inclusive of a small deferred consideration.
The table below gives details of the realisations completed during the reporting period, including the exit from Quorum Cyber, which completed in June 2024:
| Realisations | Year first invested |
Complete/ partial exit |
Cost of shares disposed of £'000 |
Value at 31 December 2023 £'000 |
Sales proceeds £'000 |
Realised gain/ (loss) £'000 |
Gain/(loss) over 31 December 2023 value £'000 |
|---|---|---|---|---|---|---|---|
| Unlisted | |||||||
| GradTouch Limited | 2019 | Complete | 200 | 292 | 303 | 103 | 11 |
| Project Falcon Topco Limited (trading as Quorum Cyber) |
2021 | Complete | 419 | 419 | 1,278 | 859 | 859 |
| Other unlisted | 3 | - | 14 | 11 | 14 | ||
| Total unlisted | 622 | 711 | 1,595 | 973 | 884 | ||
| AIM quoted | |||||||
| Faron Pharmaceuticals Oy | 2019 | Complete | 71 | 83 | 48 | (23) | (35) |
| Oncimmune Holdings PLC | 2021 | Complete | 100 | 14 | 13 | (87) | (1) |
| RUA Life Sciences PLC | 2020 | Complete | 133 | 37 | 42 | (91) | 5 |
| Verici Dx PLC | 2020 | Partial | 65 | 31 | 26 | (39) | (5) |
| Total AIM quoted | 369 | 165 | 129 | (240) | (36) | ||
| Money market funds1 | |||||||
| Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3) |
2023 | Partial | 1,000 | 1,000 | 1,000 | - | - |
| Goldman Sachs Sterling Liquid Reserves (Institutional) |
2024 | Complete | 1,000 | - | 1,000 | - | - |
| HSBC Sterling Liquidity Fund (Class A) |
2023 | Complete | 1,000 | 1,000 | 1,000 | - | - |
| Total money market funds | 3,000 | 2,000 | 3,000 | - | - |
| Realisations | Year first invested |
Complete/ partial exit |
Cost of shares disposed of £'000 |
Value at 31 December 2023 £'000 |
Sales proceeds £'000 |
Realised gain/ (loss) £'000 |
Gain/(loss) over 31 December 2023 value £'000 |
|---|---|---|---|---|---|---|---|
| Open-ended investment companies1 | |||||||
| Royal London Short Term Money Market Fund (Class Y Income) |
2023 | Partial | 986 | 983 | 974 | (12) | (9) |
| Total open-ended investment companies |
986 | 983 | 974 | (12) | (9) | ||
| Total realisations | 4,977 | 3,859 | 5,698 | 721 | 839 |
1 Realisations completed as part of the treasury management strategy.
During the year, one private company was struck off the Register of Companies, resulting in a total realised loss of £249,000 (cost £249,000). This had no effect on the NAV of the Company, as a full provision had been taken against the value of the holding in a previous period.
Since 30 June 2024, two new private company holdings have been added to the portfolio:
The principal and emerging risks and uncertainties facing the Company were set out in full in the Strategic Report contained within the 2023 Annual Report, and are the risks associated with investment in small and medium sized unlisted and AIM quoted companies which, by their nature, carry a higher level of risk and are subject to lower liquidity than investments in larger quoted companies. The valuation of investee companies may be affected by economic conditions, the credit environment and other risks, including legislation, regulation, adherence to VCT qualifying rules and the effectiveness of the internal controls operated by the Company and the Manager. These risks and procedures are reviewed regularly by the Risk Committee and reported to your Board. The Board continues to monitor the criteria for VCT qualifying status and can confirm that these are being adhered to.
Global conflict and political instability was added to the Risk Register as an emerging risk during a previous period, as the Directors were not only aware of the heightened cyber security risk but were mindful of the impact that any change in the underlying economic conditions could have on the valuation of investment companies. These included fluctuating interest rates, increased fuel and energy costs, and the availability of bank finance, all of which could be impacted during times of geopolitical uncertainty and volatile markets. The Board and the Manager continue to monitor the impact of geopolitical issues, and wider market conditions, on portfolio companies.
In order to maintain an orderly market in the Company's shares, the Directors have delegated authority to the Manager to enable the Company to buy back shares in the secondary market for cancellation or to be held in treasury, subject always to such transactions being in the best interests of Shareholders.
It is intended that the Company will seek to buy back shares with a view to maintaining a share price that is at a discount of approximately 5% to the latest published NAV per share, subject to market conditions, availability liquidity and the maintenance of the Company's VCT qualifying status. During the period under review, 2,214,662 shares were bought back at a total cost of £1.28 million.
Shareholders should note that neither the Company nor the Manager can execute a transaction in the Company's shares and an instruction to buy or sell shares on the secondary market must be directed through a stockbroker. If a Shareholder wishes to discuss a transaction, they or their broker can contact the Company's stockbroker, Shore Capital Stockbrokers on 020 7647 8132. Such transactions are, however, prohibited whilst the Company is in a closed period, which is the time from the end of a reporting period until the announcement of the relevant results, or the release of an unaudited NAV. Additionally, a closed period may be introduced if the Directors and Manager are in possession of price sensitive information.
During the period under review, there were no further amendments to the rules governing VCTs, and your Company remains fully compliant with the complex conditions and requirements as set out by HMRC.
Although the precise details of the new Government's economic and fiscal policy are currently unknown, the Manager has, through the VCT Association (VCTA), been actively involved in positive cross party dialogue to promote and reinforce the important role that VCTs play in supporting some of Britain's brightest and most entrepreneurial smaller companies, whilst also assisting in job creation across the regions. It is pleasing to note that, on 3 September 2024, HM Treasury approved the regulations required to lift the "sunset clause" and extend VCT and EIS schemes until 2035. This provides greater certainty to SME's seeking growth capital that VCTs will remain a central component of the UK's funding infrastructure.
Consistent with industry best practice, the Board and the Manager continue to apply the International Private Equity and Venture Capital Valuation (IPEV) Guidelines as the central methodology for all private company valuations. The IPEV Guidelines are the prevailing framework for fair value assessment in the private equity and venture capital industry. The Directors and the Manager continue to follow industry guidelines and adhere to the IPEV Guidelines in all private company valuations. In accordance with normal market practice, investments quoted on AIM, or another recognised stock exchange, are valued at their closing bid price at the period end.
Whilst the Manager continues to enhance its ESG framework, it should be noted that your Company's investment policy does not incorporate specific ESG aims, and portfolio companies are not required to meet any specific targets. However, as a growth investor, Maven is well positioned to help each company establish robust ESG practices at an early stage of its corporate development, ensuring that they are ingrained in the culture as the business grows. The Manager believes that strong core ESG credentials help support responsible growth and encourage positive social and environmental behaviours.
Your Company has multiple investments in companies with strong ESG credentials that are achieving growth in expanding markets. The Manager is committed to maintaining a responsible approach to new and existing investments, and has developed a framework for promoting ESG credentials by actively engaging with portfolio companies, taking into consideration material issues at the point of investment as well as monitoring progress annually. All potential investee companies are required to complete an ESG assessment that covers ten key areas and provides a comprehensive pre-investment evaluation of the business, with a focus on governance, board composition and culture, alongside environmental and social considerations.
The Manager continues to be an active signatory to the UN Principles for Responsible Investment (UNPRI) and Investing in Women Code. Alongside these external initiatives, Maven has developed diversity initiatives, including launching a Female Founder Funding programme that aims to offer mentorship and collaboration opportunities to female entrepreneurs across the UK.
Whilst M&A activity in 2023 was stifled by market uncertainty and geopolitical concerns, there has been a strong recovery in the year to date and it is pleasing to note the completion of several high value exits. The companies in the unlisted portfolio continue to attract regular acquisition interest from a range of UK and international buyers, and completing further profitable exits to help support your Company's ongoing dividend programme remains a key objective for the second half of the year.
Fraser Gray Chairman
18 September 2024
| Investment | Valuation £'000 |
Cost £'000 |
% of total assets |
% of equity held |
% of equity held by other clients1 |
|---|---|---|---|---|---|
| Unlisted | |||||
| Horizon Ceremonies Limited (trading as Horizon Cremation) |
4,769 | 2,463 | 5.3 | 12.9 | 39.7 |
| BioAscent Discovery Limited | 4,713 | 1,532 | 5.2 | 26.1 | 13.9 |
| MirrorWeb Limited | 4,179 | 990 | 4.7 | 8.5 | 41.4 |
| Bright Network (UK) Limited | 3,218 | 1,706 | 3.6 | 9.8 | 29.3 |
| Rockar 2016 Limited (trading as Rockar) |
3,110 | 1,766 | 3.5 | 6.2 | 13.2 |
| WaterBear Education Limited | 2,905 | 987 | 3.3 | 19.9 | 18.9 |
| QikServe Limited | 2,038 | 1,674 | 2.3 | 7.6 | 8.2 |
| HCS Control Systems Group Limited | 1,942 | 1,201 | 2.2 | 10.7 | 25.8 |
| Ensco 969 Limited (trading as DPP) | 1,857 | 1,532 | 2.1 | 7.4 | 27.1 |
| CB Technology Group Limited | 1,813 | 1,097 | 2.0 | 18.6 | 56.4 |
| Novatus Global Limited | 1,649 | 562 | 1.8 | 3.5 | 15.2 |
| NorthRow Limited | 1,482 | 1,699 | 1.7 | 12.3 | 20.5 |
| Vodat Communications Group (VCG) Holding Limited |
1,427 | 1,240 | 1.6 | 8.4 | 23.5 |
| Zinc Digital Business Solutions Limited |
1,301 | 867 | 1.5 | 15.6 | 28.0 |
| Summize Limited | 1,275 | 796 | 1.4 | 4.0 | 30.3 |
| Relative Insight Limited | 1,201 | 1,201 | 1.3 | 5.7 | 25.6 |
| Filtered Technologies Limited | 1,184 | 1,100 | 1.3 | 9.7 | 15.8 |
| Hublsoft Group Limited | 1,138 | 922 | 1.3 | 7.3 | 16.4 |
| ebb3 Limited | 1,125 | 1,307 | 1.3 | 31.4 | 47.5 |
| Martel Instruments Holdings Limited | 1,038 | 701 | 1.2 | 14.7 | 29.6 |
| Liftango Group Limited | 1,016 | 1,016 | 1.1 | 6.3 | 34.4 |
| Whiterock Group Limited | 1,014 | 1,014 | 1.1 | 11.2 | 26.7 |
| RevLifter Limited | 1,000 | 1,000 | 1.1 | 10.2 | 16.4 |
| 2degrees Limited (trading as Manufacture 2030) |
970 | 698 | 1.1 | 2.5 | 8.6 |
| Investment | Valuation £'000 |
Cost £'000 |
% of total assets |
% of equity held |
% of equity held by other clients1 |
|---|---|---|---|---|---|
| Unlisted (continued) | |||||
| Bud Systems Limited | 953 | 762 | 1.1 | 4.1 | 13.5 |
| CYSIAM Limited | 944 | 448 | 1.1 | 5.8 | 22.0 |
| Nano Interactive Group Limited | 929 | 625 | 1.0 | 3.7 | 11.2 |
| Boomerang Commerce Inc (trading as CommerceIQ)2 |
873 | 1,164 | 1.0 | 0.2 | 0.3 |
| DiffusionData Limited | 853 | 625 | 1.0 | 3.1 | 14.9 |
| Precursive Limited | 750 | 750 | 0.8 | 5.5 | 29.0 |
| Flow UK Holdings Limited | 735 | 1,047 | 0.8 | 12.7 | 22.3 |
| Cat Tech International Limited | 717 | 1,115 | 0.8 | 8.4 | 21.6 |
| ORCHA Health Limited | 709 | 709 | 0.8 | 2.8 | 5.0 |
| Growth Capital Ventures Limited | 650 | 639 | 0.7 | 11.5 | 36.0 |
| Maven Capital (Marlow) Limited | 650 | 650 | 0.7 | - | 100.0 |
| Delio Limited | 644 | 1,294 | 0.7 | 6.0 | 11.6 |
| XR Games Limited | 639 | 299 | 0.7 | 1.7 | 21.5 |
| Draper & Dash Limited (trading as RwHealth) |
621 | 621 | 0.7 | 6.0 | 43.0 |
| mypura.com Group Limited (trading as Pura) |
608 | 409 | 0.7 | 1.6 | 21.2 |
| CODILINK UK Limited (trading as Coniq) |
600 | 400 | 0.7 | 1.1 | 3.8 |
| Metrion Biosciences Limited | 597 | 597 | 0.7 | 4.3 | 13.9 |
| Plyable Limited | 597 | 597 | 0.7 | 6.8 | 19.8 |
| Sensoteq Limited | 597 | 597 | 0.7 | 5.6 | 18.0 |
| Enpal Limited (trading as Guru Systems) |
581 | 581 | 0.7 | 3.2 | 18.4 |
| The Algorithm People Limited (trading as Optimize) |
558 | 420 | 0.6 | 6.1 | 10.2 |
| TC Communications Holdings Limited | 551 | 958 | 0.6 | 12.6 | 22.7 |
| iAM Compliant Limited | 492 | 298 | 0.6 | 3.9 | 45.3 |
| Horizon Technologies Consultants Limited |
466 | 448 | 0.5 | 3.1 | 14.1 |
| Investment | Valuation £'000 |
Cost £'000 |
% of total assets |
% of equity held |
% of equity held by other clients1 |
|---|---|---|---|---|---|
| Unlisted (continued) | |||||
| Biorelate Limited | 419 | 348 | 0.5 | 2.0 | 23.7 |
| Laverock Therapeutics Limited | 398 | 398 | 0.4 | 1.9 | 7.5 |
| Shortbite Limited (trading as Fixtuur) | 347 | 798 | 0.4 | 10.0 | 60.8 |
| HiveHR Limited | 346 | 346 | 0.4 | 4.4 | 40.2 |
| Snappy Shopper Limited | 309 | 309 | 0.3 | 0.4 | 1.3 |
| AMufacture Limited | 261 | 261 | 0.3 | 4.8 | 15.2 |
| Alderley Lighthouse Labs Limited | 249 | 249 | 0.3 | 6.7 | 46.9 |
| Zing TopCo Limited (trading as Zing) | 185 | 185 | 0.2 | 4.9 | 42.8 |
| McKenzie Intelligence Services Limited | 159 | 159 | 0.2 | 1.6 | 4.8 |
| ISN Solutions Group Limited | 143 | 467 | 0.2 | 7.8 | 47.2 |
| Reed Thermoformed Packaging Limited (trading as iPac Packaging Innovations) |
140 | 100 | 0.2 | 0.5 | 11.8 |
| Rico Developments Limited (trading as Adimo) |
100 | 200 | 0.1 | 1.6 | 8.3 |
| Other unlisted investments | 19 | 3,699 | - | ||
| Total unlisted | 66,753 | 52,643 | 74.9 | ||
| AIM quoted3 | |||||
| GENinCode PLC | 454 | 760 | 0.6 | 6.4 | 15.3 |
| MaxCyte Inc | 383 | 207 | 0.5 | 0.1 | 0.1 |
| Kanabo Group PLC4 | 330 | 2,986 | 0.4 | 3.7 | 6.3 |
| Diaceutics PLC | 260 | 161 | 0.3 | 0.3 | 0.3 |
| Intelligent Ultrasound Group PLC | 248 | 400 | 0.3 | 1.2 | 0.8 |
| Oxford Metrics PLC | 231 | 80 | 0.3 | 0.2 | - |
| Verici Dx PLC | 112 | 373 | 0.1 | 1.1 | 0.3 |
| Eden Research PLC | 111 | 160 | 0.1 | 0.5 | 1.0 |
| KRM22 PLC | 110 | 220 | 0.1 | 1.2 | - |
| SkinBioTherapeutics PLC | 110 | 208 | 0.1 | 0.7 | - |
| Investment | Valuation £'000 |
Cost £'000 |
% of total assets |
% of equity held |
% of equity held by other clients1 |
|---|---|---|---|---|---|
| AIM quoted3 (continued) | |||||
| One Media IP Group PLC | 106 | 186 | 0.1 | 1.2 | - |
| C4X Discovery Holdings PLC | 96 | 137 | 0.1 | 0.4 | 0.5 |
| Creo Medical Group PLC | 89 | 497 | 0.1 | 0.1 | - |
| TPXimpact Holdings PLC | 66 | 107 | 0.1 | 0.2 | - |
| Pulsar Group PLC (formerly Access Intelligence PLC) |
61 | 35 | 0.1 | 0.1 | 0.4 |
| AFC Energy PLC | 59 | 57 | 0.1 | - | - |
| Cambridge Cognition Holdings PLC | 59 | 62 | 0.1 | 0.4 | 1.1 |
| Avacta Group PLC | 54 | 16 | 0.1 | - | - |
| Vianet Group PLC | 43 | 49 | - | 0.1 | 1.3 |
| Feedback PLC | 42 | 121 | - | 0.4 | 1.2 |
| Destiny Pharma PLC | 27 | 206 | - | 0.3 | 0.3 |
| Crossword Cybersecurity PLC | 24 | 122 | - | 0.4 | 1.7 |
| Spectral AI Inc | 22 | 99 | - | - | - |
| Angle PLC | 19 | 82 | - | 0.1 | - |
| Hardide PLC | 15 | 122 | - | 0.3 | 0.2 |
| ReNeuron Group PLC | 13 | 277 | - | 0.7 | 1.4 |
| Other quoted investments | 26 | 1,071 | - | ||
| Total AIM quoted | 3,170 | 8,801 | 3.6 | ||
| Private equity investment trusts5 | |||||
| HgCapital Trust PLC | 1,012 | 531 | 1.1 | - | 0.1 |
| Patria Private Equity Trust PLC (formerly abrdn Private Equity Opportunities Trust PLC) |
516 | 367 | 0.6 | 0.1 | 0.2 |
| ICG Enterprise Trust PLC | 483 | 381 | 0.5 | 0.1 | 0.1 |
| Partners Group Private Equity Limited (formerly Princess Private Equity Holding Limited) |
379 | 336 | 0.4 | 0.1 | 0.1 |
| Apax Global Alpha Limited | 370 | 344 | 0.4 | - | 0.1 |
| CT Private Equity Trust PLC | 362 | 293 | 0.4 | 0.1 | 0.3 |
| Investment | Valuation £'000 |
Cost £'000 |
% of total assets |
% of equity held |
% of equity held by other clients1 |
|---|---|---|---|---|---|
| Private equity investment trusts5 (continued) | |||||
| NB Private Equity Partners Limited | 360 | 371 | 0.4 | 0.1 | 0.2 |
| HarbourVest Global Private Equity Limited |
268 | 153 | 0.3 | - | - |
| Pantheon International PLC | 144 | 99 | 0.2 | - | 0.1 |
| Total private equity investment trusts | 3,894 | 2,875 | 4.3 | ||
| Infrastructure investment trusts5 | |||||
| 3i Infrastructure PLC | 256 | 260 | 0.3 | - | - |
| BBGI Global Infrastructure SA | 248 | 280 | 0.3 | - | 0.1 |
| International Public Partnerships Limited |
238 | 270 | 0.3 | - | - |
| Pantheon Infrastructure PLC | 225 | 250 | 0.3 | 0.1 | 0.2 |
| JLEN Environmental Assets Group Limited |
187 | 260 | 0.2 | - | 0.1 |
| Total infrastructure investment trusts | 1,154 | 1,320 | 1.4 | ||
| Fixed income investment trusts5 | |||||
| TwentyFour Income Fund Limited | 175 | 195 | 0.2 | 0.1 | - |
| Alcentra European Floating Rate Income Fund Limited |
9 | 11 | - | - | - |
| Total fixed income investment trusts | 184 | 206 | 0.2 | ||
| Global equity investment trusts5 | |||||
| Alliance Trust PLC | 181 | 149 | 0.2 | - | - |
| JPMorgan Global Growth & Income PLC |
157 | 125 | 0.2 | - | - |
| Total global equity investment trusts | 338 | 274 | 0.4 | ||
| Real estate investment trusts5 | |||||
| Impact Healthcare REIT PLC | 207 | 235 | 0.2 | 0.1 | 0.1 |
| Total real estate investment trusts | 207 | 235 | 0.2 |
| Investment | Valuation £'000 |
Cost £'000 |
% of total assets |
% of equity held |
% of equity held by other clients1 |
|---|---|---|---|---|---|
| Open-ended investment companies5 | |||||
| Royal London Short Term Fixed Income Fund (Class Y Income) |
1,028 | 1,020 | 1.2 | 0.1 | 0.2 |
| Royal London Short Term Money Market Fund (Class Y Income) |
1,008 | 1,026 | 1.1 | - | - |
| Total open-ended investment companies | 2,036 | 2,046 | 2.3 | ||
| Money market funds5 | |||||
| Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3) |
1,000 | 1,000 | 1.1 | - | - |
| Aviva Investors Sterling Government Liquidity Fund |
1,000 | 1,000 | 1.1 | - | - |
| BlackRock Institutional Sterling Government Liquidity Fund (Core Dis) |
1,000 | 1,000 | 1.1 | - | - |
| BlackRock Institutional Sterling Liquidity Fund (Core) |
1,000 | 1,000 | 1.1 | - | - |
| Fidelity Institutional Liquidity Sterling Fund (Class F) |
1,000 | 1,000 | 1.1 | 0.1 | 0.2 |
| Total money market funds | 5,000 | 5,000 | 5.5 | ||
| Total investments | 82,736 | 73,400 | 92.8 |
1 Other clients of Maven Capital Partners UK LLP.
2 This holding reflects the retained minority interest following the sale of e.fundamentals (Group) Limited to CommerceIQ in July 2022.
3 Investments are quoted on AIM with the exception of Kanabo Group PLC, which is listed on the Main Market of the London Stock Exchange.
4 The holding in this investment resulted from the sale of The GP Service (UK) Limited, which completed in February 2022. The unlisted shares in Kanabo GP Limited were, in accordance with the terms of the original transaction, exchanged for shares in Kanabo Group PLC, which is listed on the Main Market of the London Stock Exchange.
5 Treasury management portfolio.
Shaded line indicates that the investment was completed pre November 2015.
The chart below shows the profile of the portfolio by industry sector, and demonstrates the broad end market exposure. This analysis excludes cash balances and treasury management holdings.

The chart below provides insight into the age of investments within the portfolio2.


1 The market exposure within this sector is widely diversified, including automotive, cyber security, data analytics, fintech and regtech businesses.
2 The age of investments is determined by the date at which the Company first invested.
| Six months ended 30 June 2024 (unaudited) |
Six months ended 30 June 2023 (unaudited) |
Year ended 31 December 2023 (audited) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
|
| Gain/(loss) on investments | - | 3,630 | 3,630 | - | (1,689) | (1,689) | - | (2,989) | (2,989) |
| Income from investments | 792 | - | 792 | 561 | - | 561 | 1,262 | - | 1,262 |
| Other income | 87 | - | 87 | 176 | - | 176 | 299 | - | 299 |
| Investment management fees | (212) | (850) | (1,062) | (225) | (898) | (1,123) | (449) | (1,797) | (2,246) |
| Other expenses | (222) | - | (222) | (286) | - | (286) | (633) | - | (633) |
| Net return on ordinary activities before taxation |
445 | 2,780 | 3,225 | 226 | (2,587) | (2,361) | 479 | (4,786) | (4,307) |
| Tax on ordinary activities | - | - | - | - | - | - | - | - | - |
| Return attributable to Equity Shareholders |
445 | 2,780 | 3,225 | 226 | (2,587) | (2,361) | 479 | (4,786) | (4,307) |
| Earnings per share (pence) | 0.32 | 1.97 | 2.29 | 0.17 | (1.92) | (1.75) | 0.35 | (3.52) | (3.17) |
All gains and losses are recognised in the Income Statement.
The total column of this statement is the Profit & Loss Account of the Company. The revenue and capital return columns are prepared in accordance with the AIC SORP. All items in the above statement derive from continuing operations. No operations were acquired or discontinued during the period.
There are no potentially dilutive capital instruments in issue and, therefore, no diluted earnings per share figures are relevant. The basic and diluted earnings per share are, therefore, identical.
| Non-distributable reserves | ||||||||
|---|---|---|---|---|---|---|---|---|
| Six months ended 30 June 2024 (unaudited) |
Share capital £'000 |
Share premium account £'000 |
Capital redemption reserve £'000 |
Capital reserve unrealised £'000 |
Capital reserve realised £'000 |
Special distributable reserve £'000 |
Revenue reserve £'000 |
Total £'000 |
| At 31 December 2023 | 13,596 | 43,470 | 1,196 | 9,150 | 4,174 | 10,883 | 1,448 | 83,917 |
| Net return | - | - | - | 2,739 | 891 | (850) | 445 | 3,225 |
| Dividends paid | - | - | - | - | - | (2,295) | (215) | (2,510) |
| Repurchase and cancellation of shares | (221) | - | 221 | - | - | (1,285) | - | (1,285) |
| Net proceeds of share issue | 916 | 4,657 | - | - | - | - | - | 5,573 |
| Net proceeds of DIS issue* | 42 | 188 | - | - | - | - | - | 230 |
| At 30 June 2024 | 14,333 | 48,315 | 1,417 | 11,889 | 5,065 | 6,453 | 1,678 | 89,150 |
| Non-distributable reserves | Distributable reserves | |||||||
|---|---|---|---|---|---|---|---|---|
| Six months ended 30 June 2023 (unaudited) |
Share capital £'000 |
Share premium account £'000 |
Capital redemption reserve £'000 |
Capital reserve unrealised £'000 |
Capital reserve realised £'000 |
Special distributable reserve £'000 |
Revenue reserve £'000 |
Total £'000 |
| At 31 December 2022 | 12,977 | 37,443 | 762 | 12,100 | 4,213 | 19,975 | 1,174 | 88,644 |
| Net return | - | - | - | (1,893) | 204 | (898) | 226 | (2,361) |
| Dividends paid | - | - | - | - | - | (2,328) | (68) | (2,396) |
| Repurchase and cancellation of shares | (177) | - | 177 | - | - | (1,145) | - | (1,145) |
| Net proceeds of share issue | 978 | 5,729 | - | - | - | - | - | 6,707 |
| Net proceeds of DIS issue* | 37 | 208 | - | - | - | - | - | 245 |
| At 30 June 2023 | 13,815 | 43,380 | 939 | 10,207 | 4,417 | 15,604 | 1,332 | 89,694 |
| Year ended 31 December 2023 (audited) |
Share capital £'000 |
Share premium account £'000 |
Non-distributable reserves Capital redemption reserve £'000 |
Capital reserve unrealised £'000 |
Capital reserve realised £'000 |
Distributable reserves Special distributable reserve £'000 |
Revenue reserve £'000 |
Total £'000 |
|---|---|---|---|---|---|---|---|---|
| At 31 December 2022 | 12,977 | 37,443 | 762 | 12,100 | 4,213 | 19,975 | 1,174 | 88,644 |
| Net return | - | - | - | (2,950) | (39) | (1,797) | 479 | (4,307) |
| Dividends paid | - | - | - | - | - | (4,580) | (205) | (4,785) |
| Repurchase and cancellation of shares | (434) | - | 434 | - | - | (2,715) | - | (2,715) |
| Net proceeds of share issue | 978 | 5,615 | - | - | - | - | - | 6,593 |
| Net proceeds of DIS issue* | 75 | 412 | - | - | - | - | - | 487 |
| At 31 December 2023 | 13,596 | 43,470 | 1,196 | 9,150 | 4,174 | 10,883 | 1,448 | 83,917 |
*DIS represents the Dividend Investment Scheme as detailed on page 11.
The capital reserve unrealised is generally non-distributable other than the part of the reserve relating to gains/(losses) attributable to readily realisable quoted investments that are distributable.
Where all, or an element, of the proceeds of sales have not been received in cash or cash equivalents, and are not readily convertible to cash, they do not qualify as realised gains for the purposes of distributable reserves calculations and, therefore, do not form part of distributable reserves.
BALANCE SHEET
| 30 June 2024 (unaudited) £'000 |
30 June 2023 (unaudited) £'000 |
31 December 2023 (audited) £'000 |
|
|---|---|---|---|
| Fixed assets Investments at fair value through profit or loss |
82,736 | 74,919 | 77,237 |
| Current assets Debtors |
1,486 | 1,542 | 1,506 |
| Cash | 5,243 | 13,419 | 5,458 |
| 6,729 | 14,961 | 6,964 | |
| Creditors | |||
| Amounts falling due within one year | (315) | (186) | (284) |
| Net current assets | 6,414 | 14,775 | 6,680 |
| Net assets | 89,150 | 89,694 | 83,917 |
| Capital and reserves | |||
| Called up share capital | 14,333 | 13,815 | 13,596 |
| Share premium account | 48,315 | 43,380 | 43,470 |
| Capital redemption reserve | 1,417 | 939 | 1,196 |
| Capital reserve - unrealised | 11,889 | 10,207 | 9,150 |
| Capital reserve - realised | 5,065 | 4,417 | 4,174 |
| Special distributable reserve | 6,453 | 15,604 | 10,883 |
| Revenue reserve | 1,678 | 1,332 | 1,448 |
| Net assets attributable to Ordinary Shareholders |
89,150 | 89,694 | 83,917 |
| Net asset value per Ordinary Share (pence) |
62.19 | 64.92 | 61.71 |
The Financial Statements of Maven Income and Growth VCT 4 PLC, registered number SC272568, were approved by the Board and were signed on its behalf by:
Fraser Gray Director
| Six months ended 30 June 2024 (unaudited) £'000 |
Six months ended 30 June 2023 (unaudited) £'000 |
Year ended 31 December 2023 (audited) £'000 |
|
|---|---|---|---|
| Net cash flows from operating activities |
(612) | (662) | (1,308) |
| Cash flows from investing activities |
|||
| Purchase of investments | (7,567) | (11,150) | (19,583) |
| Sale of investments | 5,861 | 1,468 | 6,320 |
| Net cash flows from investing activities |
(1,706) | (9,682) | (13,263) |
| Cash flows from financing activities |
|||
| Equity dividends paid | (2,510) | (2,396) | (4,785) |
| Net proceeds of DIS issue | 234 | 245 | 6,707 |
| Issue of Ordinary Shares | 5,664 | 6,707 | 470 |
| Repurchase of Ordinary Shares | (1,285) | (1,145) | (2,715) |
| Net cash flows from financing activities |
2,103 | 3,411 | (323) |
| Net decrease in cash | (215) | (6,933) | (14,894) |
| Cash at beginning of period | 5,458 | 20,352 | 20,352 |
| Cash at end of period | 5,243 | 13,419 | 5,458 |
The financial information for the six months ended 30 June 2024 and the six months ended 30 June 2023 comprises non-statutory accounts within the meaning of S435 of the Companies Act 2006. The financial information contained in this report has been prepared on the basis of the accounting policies set out in the Annual Report and Financial Statements for the year ended 31 December 2023, which have been filed at Companies House and contained an Auditor's Report that was not qualified and did not contain a statement under S498(2) or S498(3) of the Companies Act 2006.
The share premium account represents the premium above nominal value received by the Company on issuing shares net of issue costs, including £67,880 current period trail commission (cumulative £181,574). This reserve is non-distributable.
The nominal value of shares repurchased and cancelled is represented in the capital redemption reserve. This reserve is non-distributable.
Increases and decreases in the fair value of investments are recognised in the Income Statement and are then transferred to the capital reserve unrealised account. This reserve is generally non-distributable, other than the part of the reserve relating to gains/(losses) attributable to readily realisable quoted investments that are distributable.
Gains or losses on investments realised in the year that have been recognised in the Income Statement are transferred to the capital reserve realised account on disposal. Furthermore, any prior unrealised gains or losses on such investments are transferred from the capital reserve unrealised account to the capital reserve realised account on disposal. This reserve is distributable.
The total cost to the Company of the repurchase and cancellation of shares is represented in the special distributable reserve account. The special distributable reserve also represents capital dividends, capital investment management fees and the tax effect of capital items. This reserve is distributable.
The revenue reserve represents accumulated profits retained by the Company that have not been distributed to Shareholders. This reserve is distributable.
| Six months ended 30 June 2024 |
|
|---|---|
| The returns per share have been based on the following figures: |
|
| Weighted average number of Ordinary Shares | 141,047,313 |
| Revenue return | £445,000 |
| Capital return | £2,780,000 |
| Total return | £3,225,000 |
The Directors confirm that, to the best of their knowledge:
By order of the Board Maven Capital Partners UK LLP Secretary
18 September 2024
Measures of performance that are in addition to the statutory measures reported in the Financial Statements. The APMs used by the Company are marked * in this Glossary. The Financial History table on page 6 shows the movement in net asset value and NAV total return per Ordinary Share over the past three financial periods, and shows the dividends paid on a cumulative basis since inception.
The total dividends paid for the financial year expressed as a percentage of the NAV per Ordinary Share at the preceding year end.
A discount is the percentage by which the mid-market price of an Ordinary Share is lower than the NAV per Ordinary Share. A premium is the percentage by which the midmarket price exceeds the NAV per Ordinary Share.
Comprises capital reserve (realised), revenue reserve and special distributable reserve. Within capital reserve (unrealised), there is an element of distributable reserves in relation to level 1 and level 2 investments, which can be converted readily to cash and could be considered realised.
The total of all dividends per Ordinary Share paid or proposed by the Company in respect of the financial year.
The total of all dividends per Ordinary Share paid by the Company.
The net income after tax of the Company divided by the weighted average number of shares in issue during the period. In a venture capital trust, this is made up of revenue EPS and capital EPS.
The date set by the London Stock Exchange, normally being the business day preceding the record date.
A market index calculates the average performance of its constituents, normally on a weighted basis. It provides a means of assessing the overall state of the economy and provides a comparison against which the performance of individual investments can be assessed.
Income from investments as reported in the Income Statement.
Net assets divided by the number of Ordinary Shares in issue.
Net assets divided by the number of Ordinary Shares in issue, plus cumulative dividends paid per Ordinary Share to date.
Total assets less current and long-term liabilities.
The total recurring annual running expenses (including management fees charged to the capital reserve) as a percentage of the average net assets attributable to Shareholders.
The total of investment management fees and other expenses as reported in the Income Statement.
The profit/loss on the sale of investments during the period.
The date on which an investor needs to be holding a share in order to qualify for a forthcoming dividend.
The total of undistributed revenue earnings from prior periods. This is available for distribution to Shareholders by way of dividend payments.
The theoretical return, including reinvesting each dividend in additional shares in the Company at the closing mid-market price on the day that the shares go ex-dividend.
The profit/loss on the revaluation of the investment portfolio at the end of the period.
Fraser Gray (Chairman) Brian Colquhoun Bill Nixon Steven Scott
Maven Capital Partners UK LLP Kintyre House 205 West George Street Glasgow G2 2LW Telephone: 0141 306 7400 Email: [email protected]
Kintyre House 205 West George Street Glasgow G2 2LW
Company Registration Number: SC272568 Legal Entity Identifier: 213800WSH2TNL9NG5I06 TIDM: MAV4 ISIN: GB00B043QW84
The City Partnership (UK) Limited The Mending Rooms Park Valley Mills Meltham Road Huddersfield HD4 7BH Email: [email protected]
Investor hub: maven-cp.cityhub.uk.com
Telephone: 01484 240910 (Lines are open from 9.00 am to 5.30 pm, Monday to Friday)
Johnston Carmichael LLP
JPMorgan Chase Bank
Shore Capital Stockbrokers Limited Telephone: 020 7647 8132
Philip Hare & Associates LLP
(a subsidiary of Mattioli Woods Limited)
Kintyre House 205 West George Street Glasgow G2 2LW
Tel: 0141 306 7400
Authorised and Regulated by The Financial Conduct Authority



Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.